Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥136.03B | 17x | -1.32 | CN¥52.87 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.1% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥53.76B | 56.2x | -0.96 | CN¥62.42 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.8% Downside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥50.51B | 26.8x | 1.24 | CN¥28.41 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.9% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥23.85B | 19.8x | 0.11 | CN¥51.31 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.5% Upside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥18.85B | -21.8x | -1.09 | CN¥44.71 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.5% Upside | Upgrade to Pro+ | |
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥18.37B | -640.9x | -7.31 | CN¥39.30 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥17.89B | -187.6x | 1.03 | CN¥46.90 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥14.79B | -6.1x | 0.59 | CN¥33.14 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.1% Downside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥13.13B | -18,050x | CN¥17.78 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -18.4% Downside | Upgrade to Pro+ | ||
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥13.01B | -31.6x | -1.2 | CN¥12.71 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.25B | -24.6x | -0.6 | CN¥165.32 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥9.81B | -9.1x | 0.65 | CN¥23.80 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥9.56B | -26.6x | -0.7 | CN¥22.16 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥8.44B | 54.5x | -1.68 | CN¥67.91 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.9% Upside | Upgrade to Pro+ | |
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.99B | -19.5x | 14.9 | CN¥9.72 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41% Upside | Upgrade to Pro+ | |
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥5.94B | 42.8x | -12.84 | CN¥59.04 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.9% Downside | Upgrade to Pro+ | |
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.60B | 42.1x | -3.94 | CN¥13.42 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.3% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.51B | 102.7x | 1.55 | CN¥13.41 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.16B | -19.8x | 0.08 | CN¥37.02 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.03B | 22.5x | 2.15 | CN¥42.60 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.61B | 21x | -1.39 | CN¥41.12 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.60B | 34.4x | 1.2 | CN¥27.06 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.3% Upside | Upgrade to Pro+ | |
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.47B | -11.5x | 0.66 | CN¥7.60 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.34B | 33x | 0.73 | CN¥15.03 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.5% Downside | Upgrade to Pro+ | |
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.75B | -17.4x | -0.52 | CN¥36.46 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.71B | 472.5x | -5.54 | CN¥27.66 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.52B | 54x | -14.66 | CN¥13.82 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.42B | 77x | 1.68 | CN¥9.01 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | |
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.33B | -3.5x | 0.08 | CN¥6.68 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥2.88B | 27.4x | -1.14 | CN¥42 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |